1315 CAPITAL
Venture Capital & Private Equity, 2929 Walnut St, Philadelphia, Pennsylvania, 19104, United States, 11-50 Employees
Phone Number: +14*********
Who is 1315 CAPITAL
1315 Capital provides expansion and growth capital to commercial-stage healthcare services, medical technology, and specialty therapeutics companies, the latter including businesses focus...
Read More
-
Headquarters: 2929 Walnut St, Philadelphia, Pennsylvania, 19104, United States
-
Date Founded: 2014
-
Employees: 11-50
-
Revenue: 5 Million to 10 Million
-
Active Tech Stack: See technologies
Industry: Venture Capital & Private Equity
SIC Code: 6799
|
NAICS Code: 523130 |
Show More
Does something look wrong? Fix it. | View contact records from 1315 CAPITAL
View Employees
Email
Phone
Similar Companies to 1315 Capital
Ai Fund
-
11-50
-
$ 5 Million to 10 Million
1315 Capital Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding 1315 Capital
Answer: 1315 Capital's headquarters are located at 2929 Walnut St, Philadelphia, Pennsylvania, 19104, United States
Answer: 1315 Capital's phone number is +14*********
Answer: 1315 Capital's official website is https://1315capital.com
Answer: 1315 Capital's revenue is 5 Million to 10 Million
Answer: 1315 Capital's SIC: 6799
Answer: 1315 Capital's NAICS: 523130
Answer: 1315 Capital has 11-50 employees
Answer: 1315 Capital is in VENTURE CAPITAL & PRIVATE EQUITY
Answer: 1315 Capital top competitors include: Ai Fund, Bridge Investments, Fj Labs, Turnbridge Capital Llc, Palatine Private Equity Llp, Valhalla Partners, Petra Capital Partners, Iselect Fund, Peppertree Capital, Knightsbridge Advisers, Excelerate Health Ventures
Answer: 1315 Capital contact info: Phone number: +14********* Website: https://1315capital.com
Answer: 1315 Capital provides expansion and growth capital to commercial-stage healthcare services, medical technology, and specialty therapeutics companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$30 million investments in commercial healthcare entities that we believe have the potential to scale to approximately $100 million of revenue, a level we believe is highly attractive for acquisition or to access the public markets. In addition to experienced investing partners, 1315 Capital leverages an operating partner model of CEO and “Right Hand” COO Executive, a partnership that works together to navigate diligence, drive decisions, and seeks to achieve premium exits. Three operating teams contribute their collective experience to 1315 Capital in the areas of medical technologies, healthcare services, and specialty therapeutics. These three teams have built companies from expansion and growth phases to entities with revenues in excess of $100 million, resulting in almost $5 billion of aggregate exit value.
Answer:
Premium Sales Data for Prospecting
- Sales data across over 200M records
- Up-to-date records (less decayed data)
- Accurate Email Lists (real-world tested)
- Powerful search engine and intuitive interface
Get Full Access
View Employees
1315 Capital Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month